Courtesy of Benzinga.
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that its board of directors has authorized a $250 million extension to the company’s ongoing share repurchase authorization. The newly authorized funds will be used to repurchase company stock on the open market. The $250 million share repurchase authorization adds to the approximately $80 million remaining from the prior authorizations as of March 31, 2012.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.